Strides Pharma Science Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,194.65 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.14 per cent from ₹1,220.83 crore. This corresponds to a year-on-year *(YoY) growth of 3.55 per cent.
Operating Profit
Operating Profit stands at ₹232.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.90 per cent from ₹221.75 crore. This corresponds to a year-on-year *(YoY) growth of 11.90 per cent.
PBDT
PBDT stands at ₹296.11 crore, reflecting a quarter-on-quarter *(QoQ) increase of 46.05 per cent from ₹202.75 crore. This corresponds to a year-on-year *(YoY) growth of 82.49 per cent.
Profit Before Tax
Profit Before Tax stands at ₹245.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 60.34 per cent from ₹153.11 crore. This corresponds to a year-on-year *(YoY) growth of 115.64 per cent.
Net Profit
Net Profit stands at ₹208.13 crore, reflecting a quarter-on-quarter *(QoQ) increase of 58.25 per cent from ₹131.52 crore. This represents a 131.15 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Strides Pharma Science Ltd News
Strides Pharma Science Ltd Earnings
- YOY
- QOQ
Strides Pharma Science Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Strides Pharma Science Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Strides Pharma Science Ltd Financial Reports
Strides Pharma Science Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Strides Pharma | 4.16% | 10.96% | 14.86% | 29.27% | 23.26% | 79.38% |
| Concord Biotech | -2.46% | -0.43% | 12.89% | -6.12% | -17.38% | -22.71% |
| Sanofi Consumer | 1.82% | 0.69% | 4.39% | 13.62% | 3.12% | -2.16% |
| Corona Remedies | -0.24% | 0.27% | 10.92% | 6.10% | 20.78% | 20.78% |
| Viyash Scientific | 0.66% | 8.04% | 7.75% | 6.63% | -1.40% | 37.46% |
| Marksans Pharma | 3.46% | 7.57% | 16.05% | 8.84% | 8.61% | -10.11% |
| Jeena Sikho | -1.83% | 7.75% | 13.73% | -0.26% | 1.28% | 37.88% |
Company Info
Company Information
Chairman & Non Executive Dir. : Arun Kumar
Executive Director / WTD / Managing Director / CEO : Badree Komandur
Independent Non Exe. Director : Kausalya Santhanam
Independent Non Exe. Director : Mukta Malik Arora
Independent Non Exe. Director : Homi R Khusrokhan
Independent Non Exe. Director : Ameet Hariani
Independent Non Exe. Director : Subir Chakraborty
Executive Director / Whole Time Director : Aditya Kumar
Company Sec. & Compli. Officer : Manjula Ramamurthy